thermo fisher companion diagnostics：Thermo Fisher Scientific Signs Companion Diagnostic ...
Thermo Fisher Scientific Signs Companion Diagnostic ...
2023年10月19日—ThecompanieswillworktodevelopCDxteststohelpidentifypatientswithnon-smallcelllungcancer(NSCLC)withspecificgenomicmutations.。其他文章還包含有：「ALookInsideThermoFisher'sCDxProgramwithGarret...」、「BayerandThermoFisherScientificcollaboratetoincrease...」、「CompanionDiagnostics」、「OncomineCompanionDiagnosticsCDxNews」、「PreclinicaltoCompanionDiagnosticDevelopment」、「The...
查看更多 離開網站
A Look Inside Thermo Fisher's CDx Program with Garret ...
https://www.oncomine.com
Companion diagnostic (CDx) tests are powerful tools in precision medicine and help advance more widespread use of targeted cancer therapies.
Bayer and Thermo Fisher Scientific collaborate to increase ...
https://www.bayer.com
Bayer AG and Thermo Fisher Scientific Inc. today announced a collaboration to develop next-generation sequencing (NGS)-based companion diagnostic assays (CDx) ...
Companion Diagnostics
https://www.thermofisher.com
In close collaboration with our pharmaceutical partners, we provide solutions to assist in all stages of CDx development from the biomarker discovery ...
Oncomine Companion Diagnostics CDx News
https://www.oncomine.com
Thermo Fisher Scientific and AstraZeneca to Co-Develop NGS-based Companion Diagnostics. Multiyear, global strategic collaboration to co-develop NGS-based ...
Preclinical to Companion Diagnostic Development
https://www.thermofisher.com
Learn about targeted NGS solutions that help accelerate the move from research to clinical applications in the future, linking genes to disease states, ...
Thermo Fisher (TMO) Inks Deal to Develop Companion ...
https://finance.yahoo.com
Thermo Fisher Scientific TMO recently announced a collaboration with Bayer AG BAYRY to develop next-generation sequencing (NGS)-based companion diagnostic ...
Thermo Fisher
https://www.medtechdive.com
The companies aim to identify potential patients for Bayer's precision cancer therapies and increase access to the treatments.